Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 02, 2021 Filed Jul 6, 2021 17:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 147,727 | $232.69 | $34,374,743.36 |
DisclosureSEC source: 0001209191-21-045315 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,251,475 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.09 to $233.085, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| June 24, 2021 Filed Jun 25, 2021 17:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,200 | $238.13 | $285,757.20 |
DisclosureSEC source: 0001209191-21-043246 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,399,202 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $238.0075 to $238.27, inclusive. Read SEC document |
| June 24, 2021 Filed Jun 25, 2021 17:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 11,698 | $237.45 | $2,777,643.31 |
DisclosureSEC source: 0001209191-21-043246 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,400,402 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.00 to $237.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 20:34 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 49 | $222.67 | $10,910.83 |
DisclosureSEC source: 0000059478-21-000147 · wf-form4_162448043600293.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,802 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 20:37 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 43 | $222.67 | $9,574.81 |
DisclosureSEC source: 0000059478-21-000149 · wf-form4_162448060883036.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 20:40 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 9 | $222.67 | $2,004.03 |
DisclosureSEC source: 0000059478-21-000151 · wf-form4_162448078769770.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,266 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 14:35 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 600 | $235.67 | $141,400.80 |
DisclosureSEC source: 0001209191-21-039767 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,412,100 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold at prices of $235.665 and $235.68, inclusive. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 14:35 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 42,596 | $235.15 | $10,016,534.59 |
DisclosureSEC source: 0001209191-21-039767 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,412,700 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.65 to $235.645, inclusive. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 14:35 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 57,008 | $233.89 | $13,333,487.10 |
DisclosureSEC source: 0001209191-21-039767 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,455,296 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.635 to $234.63, inclusive. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 14:35 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 120,475 | $233.17 | $28,091,637.65 |
DisclosureSEC source: 0001209191-21-039767 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,512,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.635 to $233.63, inclusive. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 14:35 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 19,321 | $232.35 | $4,489,292.31 |
DisclosureSEC source: 0001209191-21-039767 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,632,779 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.635 to $232.63, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4) and (5) to this Form 4. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 19:35 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 870 | $226.36 | $196,933.20 |
DisclosureSEC source: 0001209191-21-039422 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,652,100 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.3333 to $226.39, inclusive. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 19:35 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 84,516 | $225.64 | $19,069,767.66 |
DisclosureSEC source: 0001209191-21-039422 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,652,970 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.27 to $226.26, inclusive. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 19:35 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 74,766 | $224.93 | $16,817,415.44 |
DisclosureSEC source: 0001209191-21-039422 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,737,486 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.27 to $225.2681, inclusive. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 19:35 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 59,848 | $223.90 | $13,400,146.74 |
DisclosureSEC source: 0001209191-21-039422 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,812,252 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.27 to $224.26, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 600 | $233.23 | $139,936.20 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 15 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,872,100 F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold at prices of $232.91 and $233.29. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,100 | $232.03 | $255,229.70 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 14 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,872,700 F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.89 to $232.88, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 6,164 | $231.36 | $1,426,084.55 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 13 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,873,800 F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.87 to $231.86, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 15,125 | $230.14 | $3,480,928.00 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 12 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,879,964 F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.85 to $230.79, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 17,321 | $229.46 | $3,974,459.34 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 11 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,895,089 F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.83 to $229.82, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 6,700 | $228.38 | $1,530,139.30 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 10 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,912,410 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.83 to $228.8247, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 10,010 | $227.27 | $2,275,012.74 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 9 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,919,110 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.79 to $227.777, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 10,627 | $226.33 | $2,405,177.03 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 8 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,929,120 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.7467 to $226.74, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 21,187 | $225.17 | $4,770,634.42 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 7 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,939,747 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.7442 to $225.73, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 33,646 | $224.27 | $7,545,822.07 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,960,934 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.743 to $224.74, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 46,716 | $223.17 | $10,425,796.58 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,994,580 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.73 to $223.7293, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 29,489 | $222.40 | $6,558,206.16 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,041,296 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.7003 to $222.70, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 14,621 | $221.12 | $3,232,966.28 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,070,785 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.61 to $221.54, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 5,625 | $220.36 | $1,239,519.38 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,085,406 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.6005 to $220.60, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 11,069 | $219.09 | $2,425,096.14 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,091,031 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $218.60 to $219.41, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), and (15) to this Form 4. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:41 UTC |
Rau DiogoSVP & CIDO
|
GrantRestricted Stock Unit · Derivative | 20,160 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000141 · wf-form4_162275644126655.xml · derivative · entry 1 Rau Diogo · CIK 0001860253 · SVP & CIDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,160 Underlying: Common Stock · 20,160 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. F2 · derivative.exercise_date: The restricted stock units vest in three installments, 7,560 on June 1, 2022, 6,300 on June 1, 2023, and 6,300 on June 1, 2024. F2 · derivative.expiration_date: The restricted stock units vest in three installments, 7,560 on June 1, 2022, 6,300 on June 1, 2023, and 6,300 on June 1, 2024. Read SEC document |
| May 24, 2021 Filed May 25, 2021 14:39 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,292 | $203.25 | $262,597.71 |
DisclosureSEC source: 0001209191-21-035631 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,102,100 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.07 to $203.46, inclusive. Read SEC document |
| May 24, 2021 Filed May 25, 2021 14:39 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 3,010 | $202.33 | $609,022.33 |
DisclosureSEC source: 0001209191-21-035631 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,103,392 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.00 to $202.89, inclusive. Read SEC document |
| May 24, 2021 Filed May 25, 2021 14:39 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 3,027 | $201.78 | $610,785.03 |
DisclosureSEC source: 0001209191-21-035631 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,106,402 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.00 to $201.98, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| May 21, 2021 Filed May 24, 2021 15:15 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 28,504 | $201.30 | $5,737,912.21 |
DisclosureSEC source: 0001209191-21-035188 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,109,429 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.00 to $201.885, inclusive. Read SEC document |
| May 21, 2021 Filed May 24, 2021 15:15 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 64,236 | $200.26 | $12,864,094.07 |
DisclosureSEC source: 0001209191-21-035188 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,137,933 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.00 to $200.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| May 20, 2021 Filed May 21, 2021 16:57 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,200 | $201.01 | $442,219.80 |
DisclosureSEC source: 0001209191-21-034809 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,202,169 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.00 to $201.035, inclusive. Read SEC document |
| May 20, 2021 Filed May 21, 2021 16:57 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 97,731 | $200.46 | $19,591,547.18 |
DisclosureSEC source: 0001209191-21-034809 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,204,369 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.00 to $200.9925, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| May 17, 2021 Filed May 19, 2021 20:27 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 56 | $195.53 | $10,949.68 |
DisclosureSEC source: 0000059478-21-000133 · wf-form4_162145604425259.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,573 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| May 17, 2021 Filed May 19, 2021 20:30 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 49 | $195.53 | $9,580.97 |
DisclosureSEC source: 0000059478-21-000135 · wf-form4_162145623122121.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| May 17, 2021 Filed May 19, 2021 20:35 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 10 | $195.53 | $1,955.30 |
DisclosureSEC source: 0000059478-21-000137 · wf-form4_162145650331377.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,205 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| April 30, 2021 Filed May 3, 2021 23:01 UTC |
TAI JACKSON PDirector
|
PurchaseCommon Stock | 546 | $182.99 | $99,912.54 |
DisclosureSEC source: 0000059478-21-000124 · wf-form4_162008288985438.xml · nonDerivative · entry 2 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,195 Read SEC document |
| April 30, 2021 Filed May 3, 2021 23:01 UTC |
TAI JACKSON PDirector
|
PurchaseCommon Stock | 820 | $182.74 | $149,846.80 |
DisclosureSEC source: 0000059478-21-000124 · wf-form4_162008288985438.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,649 Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 00:31 UTC |
Zakrowski Donald AChief Accounting Officer
|
SaleCommon Stock | 3,000 | $181.38 | $544,140.00 |
DisclosureSEC source: 0000059478-21-000120 · wf-form4_161974266436017.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,987 Read SEC document |
| April 28, 2021 Filed Feb 3, 2022 21:33 UTC |
Ricks David ADirector · President & CEO
|
GiftCommon Stock | 63,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-22-000018 · wf-form5_164392396285190.xml · nonDerivative · entry 1 Ricks David A · CIK 0001538604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376,744 F1 · shares: On April 28, 2021, the Reporting Person transferred 63,500 shares of Eli Lilly and Company common stock to a spousal lifetime access trust, of which the Reporting Person's wife is the trustee and the Reporting Person's wife and children are beneficiaries. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Read SEC document |
| April 28, 2021 Filed Feb 3, 2022 21:38 UTC |
Skovronsky DanielSVP, CS&MO & Pres. LRL
|
GiftCommon Stock | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-22-000020 · wf-form5_164392427358598.xml · nonDerivative · entry 1 Skovronsky Daniel · CIK 0001741474 · SVP, CS&MO & Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,680 F1 · balance_after: The amount reported as directly beneficially owned gives effect to a transfer on April 15, 2021 by the Reporting Person of 70,000 shares to the DMGCS Family Holdings LLC, a single-member limited liability company controlled solely by the Reporting Person until April 28, 2021, on which date 100% of the units and control of the DMGCS Family Holdings LLC were transferred for no consideration to the Reporting Person's spouse as trustee of a trust for the benefit of the Reporting Person's spouse and children as sole beneficiaries. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 20:23 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 58 | $189.64 | $10,999.12 |
DisclosureSEC source: 0000059478-21-000111 · wf-form4_161903661718601.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,517 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 20:27 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 51 | $189.64 | $9,671.64 |
DisclosureSEC source: 0000059478-21-000113 · wf-form4_161903686122680.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 20:32 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 10 | $189.64 | $1,896.40 |
DisclosureSEC source: 0000059478-21-000115 · wf-form4_161903711512243.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,829 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:36 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 51 | $189.16 | $9,647.16 |
DisclosureSEC source: 0000059478-21-000096 · wf-form4_161601335903604.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.